LC Determination of Finasteride and Its Application to Storage Stability Studies

July 2001 in “ Journal of Pharmaceutical and Biomedical Analysis ”

Akheel A. Syed, Mungalimane K. Amshumali

finasteride high-performance liquid chromatography liquid chromatography hair loss storage stability quality control analytical methods Propecia HPLC LC

Studysummary Finasteride remains stable for two years with proper storage.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

This document summarizes various studies that use high-performance liquid chromatography (HPLC) and liquid chromatography (LC) to determine the concentration and stability of finasteride, a drug used to treat hair loss. The studies found that the proposed methods were reliable and efficient, with the drug remaining stable for up to two years under proper storage conditions. The authors emphasize the importance of quality control and analytical methods in the pharmaceutical industry.

View this study on sciencedirect.com →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research The Effect of Finasteride in Men with Benign Prostatic Hyperplasia

1040 citations , October 1992 in “The New England Journal of Medicine”

In this study, 5 mg of finasteride per day significantly improved urinary symptoms and reduced prostate volume in men with benign prostatic hyperplasia, but increased the risk of sexual dysfunction.

research High-Performance Liquid Chromatographic Method for the Determination of Finasteride in Human Plasma at Therapeutic Doses

19 citations , May 1991 in “Journal of Chromatography B: Biomedical Sciences and Applications”

This study developed and validated an HPLC method for detecting a novel 5α-reductase inhibitor in human plasma, supporting its pharmacokinetic evaluation at low doses.

research Species Differences in Prostatic Steroid 5α-Reductases of Rat, Dog, and Human

193 citations , August 1985 in “Endocrinology”

This study found significant species differences in the enzyme activity and inhibitor affinities of prostatic 5α-reductases from rats, dogs, and humans, with variable potencies for different 3-oxo-4-azasteroid inhibitors across species.